Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
TALS Talaris Therapeutics
1.630
-0.140-7.91%
Post Mkt Price
1.6300.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Financial Ratios
Efficiency Ratios TTM
ROIC
-93.02% -30.481% -107.12% -26.221% -- -60.949% 29.44% -24.479%
ROE
-95.68% -30.901% -109.95% -26.579% -- -63.257% 29.44% -24.479%
ROA
-92.61% -29.755% -107.45% -25.737% -58.59% -29.723% -1.48% -23.668%
Efficiency Ratios
Profitability Ratios TTM
Financial Health Ratios
Long-Term Debt to Equity Ratio
-- 1.129% -- 1.153% -- 1.176% -- --
Total Assets to Common Equity
3.69% 105.992% 2.73% 104.828% -- 104.962% 0.31% 103.547%
Debt to Asset Ratio
-- 1.593% -- 1.549% -- 1.504% -- --
Current Ratio
-58.31% 21.6107 -50.16% 28.9233 -28.98% 28.3221 -30.31% 30.8644
Quick Ratio
-58.64% 21.1463 -50.54% 28.2515 -28.77% 27.9639 -30.62% 30.546
GrowthRatios
Growth Ratios
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its technologies are used to treat inherited metabolic enzyme disorders, red blood cell disorders to induce tolerance to organ transplants, and to treat autoimmune disorders such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Louisville, KY.
CEO: Mr. Scott Requadt
Market: NASDAQ
Listing Date: 05/07/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist